Xuqi Sun

Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients

Xuqi Sun, Jie Mei, Wen‐Ping Lin et al. · BMC Cancer · 2021 · 87 citations · Full text

Medicine, Immunology, Oncology +17

Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma

Jie Mei, Shaohua Li, QiJiong Li et al. · Journal of Hepatocellular Carcinoma · 2021 · 59 citations · Full text

Medicine, Immunology, Oncology +17

Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy

Jie Mei, Xuqi Sun, Wen‐Ping Lin et al. · Journal of Inflammation Research · 2021 · 48 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications

Xuqi Sun, Qi Zhang, Jie Mei et al. · BMC Cancer · 2022 · 38 citations · Full text

Medicine, Oncology, Pharmacology +16

Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection

Juncheng Wang, Jiancong Chen, Cai‐Ling Xiang et al. · European Journal of Cancer · 2021 · 30 citations · Full text

Medicine, Oncology, Surgery +17